Fragment-based drug discovery
In stock
Price $100 (USD)
Type New
Creative Biostructure has established a MagHelix™ FBDD Platform for early drug discovery, which covers advanced biophysical detection instruments, such as the X-ray single crystal diffractometer, high-performance nuclear magnetic resonance (NMR) instrument, and surface plasmon resonance (SPR) instrument. With the FBDD platform, we can provide customized drug discovery solutions for a wide variety of disease areas and therapeutic targets, including complex targets involving protein-protein interactions (PPI). Fragment-based drug discovery https://drug-discovery.creativ....e-biostructure.com/m
Like
Comment
Share
